David A. Boyden,
President
Dave Boyden has been in the
biopharmaceutical industry for 25 years and has a broad functional background including research, venture capital, sales and
marketing. Mr. Boyden obtained
a degree in Molecular Biology from UC San Diego and spent five years as a research scientist at Syntro, an early-stage biotech
company. He then received an M.B.A. from the Anderson School
at UCLA and worked at 3i Ventures, a biotech venture capital firm. Mr. Boyden
then spent 14 years at Amgen in a number of senior Sales and Marketing positions, including Senior Brand Director responsible
for EPOGENŽ, the world's largest biotech product, and the launch of Aranesp™. He was also Global Commercial
Leader for Aranesp™ and was involved in the development of important new indications such as CHF. Mr Boyden has extensive reimbursement, channel, and national account experience and has worked in a number
of therapeutic areas, including oncology, infectious disease, cardiology and nephrology. He formed Mirador Strategies in 2005.
